Voltaren /00372301/


Indications and Reactions:

Role Indications Reactions
Secondary
Product Used For Unknown Indication 48.0%
Cancer Pain 28.0%
Acute Coronary Syndrome 8.0%
Renal Impairment 8.0%
Somnolence 8.0%
Non-cardiac Chest Pain 50.0%
Self Injurious Behaviour 25.0%
Somnolence 25.0%
Concomitant
Product Used For Unknown Indication 32.6%
Rheumatoid Arthritis 11.4%
Prophylaxis 9.6%
Cancer Pain 8.7%
Chronic Hepatitis C 5.5%
Pain 3.9%
Hypertension 3.4%
Pleural Mesothelioma Malignant 3.3%
Pyrexia 2.7%
Osteoporosis 2.4%
Osteoarthritis 2.2%
Arthralgia 2.1%
Hepatitis C 2.1%
Insomnia 1.9%
Back Pain 1.6%
Diabetes Mellitus 1.5%
Ankylosing Spondylitis 1.3%
Supplementation Therapy 1.3%
Asthma 1.2%
Constipation 1.0%
White Blood Cell Count Decreased 15.5%
Drug Ineffective 8.3%
Weight Decreased 7.1%
Pain 6.0%
Pneumonia 6.0%
Pyrexia 4.8%
Sinusitis 4.8%
Therapeutic Response Decreased 4.8%
Upper Gastrointestinal Haemorrhage 4.8%
Vomiting 4.8%
Weight Increased 4.8%
Influenza 3.6%
Injection Site Erythema 3.6%
Malaise 3.6%
Nausea 3.6%
Rash 3.6%
Respiratory Rate Decreased 3.6%
Decreased Appetite 2.4%
Ileus 2.4%
Impaired Healing 2.4%

Drug Data